http://orcid.org/0000-0002-9790-5820
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The podoplanin-CLEC-2 axis is critical in mice for prevention of hemorrhage in the cerebral vasculature during mid-gestation. This raises the question as to how platelets are captured by podoplanin on neuroepithelial cells in a high shear environment. In this study, we demonstrate that mouse platelets form stable aggregates on mouse podoplanin at arterial shear through a CLEC-2 and Src kinase-dependent pathway. Adhesion and aggregation are also dependent on the platelet glycoprotein (GP) receptors, integrin αIIbβ3 and GPIb, and the feedback agonists ADP and thromboxane A2 (TxA2). CLEC-2 does not bind to von Willebrand factor (VWF) suggesting that the interaction with podoplanin is sufficient to both tether and activate platelets. Consistent with this, the surface plasmon resonance measurements reveal that mouse CLEC-2 binds to mouse podoplanin with nanomolar affinity. The present findings demonstrate a novel pathway of hemostasis in which podoplanin supports platelet capture and activation at arteriolar rates of shear.
Acknowledgements
The authors would like to thank Jamie R. McFarlane Webster for work performed in the protein expression facility (PEF) in the University of Birmingham in the production of the recombinant forms of podoplanin, Prof. Bernard Nieswandt for kindly providing p0p/B antibody, Beata Grygielska for technical assistance, Maria Hoellerer for expression plasmids, and Siân Lax for her assistance in preparing the manuscript.
Declaration of interest
The authors declare no known conflicts of interest
Funding
SEL is a Wellcome Trust Prize Student (ref 099850). CEH and AYP were supported by the Wellcome Trust 088410. SPW holds a BHF Chair (CH/03/003).
Supplemental data
Supplemental data for this article can be accessed on the publisher’s website.